To ensure that a patient's test is billed to their 2024 health benefits, testing must be started before the end of the year. For exome, genome, or Xpanded testing, if you do not expect parental samples to be received before the end of the year, please contact us at [email protected] to determine how to proceed.

Dystonia Panel

New York
Approved


Genes

ADAR, ADCY5, AFG3L2, ANO3, APTX, ARSA, ATM, ATP13A2, ATP1A2, ATP1A3, ATP7B, BCAP31, C19orf12, CACNA1A, CACNA1B, COASY, CP, CYP27A1, DCAF17, DDC, DLAT, DNAJC12, ECHS1, FA2H, FITM2, FTL, FUCA1, GCDH, GCH1, GLRA1, GNAL, GNAO1, HEXA, HPCA, HPRT1, KCNJ6, KCNMA1, KCTD17, KMT2B, MARS2, MCOLN1, MECR, MRE11, NKX2-1, NPC1, NPC2, NUBPL, PANK2, PDGFB, PDGFRB, PLA2G6, PNKD, PNKP, POLR3B, PRKRA, PRRT2, PTS, SCP2, SERAC1, SGCE, SLC16A2, SLC19A3, SLC20A2, SLC2A1, SLC30A10, SLC6A3, SPAST, SPR, SQSTM1, SUCLA2, SYNJ1, TH, THAP1, TIMM8A, TOR1A, TOR1AIP1, TPK1, TPP1, TRAPPC11, TUBB4A, VPS13A, WDR45, XPR1

Conditions

  • Primary Familial Brain Calcification (PFBC)
  • Myoclonus dystonia
  • Paroxysmal dyskinesia
  • Torsion dystonia
  • Combined dystonia
  • Dystonia-deafness syndromes
  • Dopa-Responsive Dystonia
  • Wilson Disease
  • Neurodegeneration with Brain Iron Accumulation (NBIA)
  • Dystonia
  • Movement Disorder
  • Tremors

Clinical Utility

  • Molecular confirmation of a clinical diagnosis
  • Identification of at-risk family members
  • Assist with treatment/ management decisions
  • Recurrence risk assessment

Lab Method

  • Next-Gen Sequencing
  • Deletion/Duplication Analysis

Test Code

T403

CPT Codes*

81404x3, 81405x5, 81406x11, 81408x1, 81185x1, 81479x3

ABN Required

No

Turnaround Time**

4 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.